Cargando…
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research ques...
Autores principales: | Terada, Mitsuo, Ito, Aki, Kikawa, Yuichiro, Koizumi, Kei, Naito, Yoichi, Shimoi, Tatsunori, Ishihara, Mikiya, Yamanaka, Takashi, Ozaki, Yukinori, Hara, Fumikata, Nakamura, Rikiya, Hattori, Masaya, Miyashita, Minoru, Kondo, Naoto, Yoshinami, Tetsuhiro, Takada, Masahiro, Matsumoto, Koji, Narui, Kazukata, Sasada, Shinsuke, Iwamoto, Takayuki, Hosoda, Mitsuchika, Takano, Yuko, Oba, Takaaki, Sakai, Hitomi, Murakami, Akari, Higuchi, Toru, Tsuchida, Junko, Tanabe, Yuko, Shigechi, Tomoko, Tokuda, Emi, Harao, Michiko, Kashiwagi, Shinichiro, Mase, Junichi, Watanabe, Junichiro, Nagai, Shigenori E., Yamauchi, Chikako, Yamamoto, Yutaka, Iwata, Hiroji, Saji, Shigehira, Toyama, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587293/ https://www.ncbi.nlm.nih.gov/pubmed/37804479 http://dx.doi.org/10.1007/s12282-023-01505-x |
Ejemplares similares
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
por: Shimoi, Tatsunori, et al.
Publicado: (2020) -
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
por: Shimoi, Tatsunori, et al.
Publicado: (2021) -
First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Shimoi, Tatsunori, et al.
Publicado: (2020) -
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
por: Yamamoto, Yutaka, et al.
Publicado: (2022) -
The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2019)